Product Images Flumazenil

This text discusses the magnitude and duration of the reversal of sedation based on different doses of Flumazenil (0.2 mg, 0.6 mg, and 1 mg) and their corresponding blood levels in ng/mL. The study involved healthy volunteers receiving Flumazenil at a dosage rate of 0.06-0.20 mg/kg/hr, resulting in complete alertness.*

This text provides pharmacokinetic data for a substance, including Crax concentration in ng/mL, AUC in ng-hr/mL, Vss in L/kg, Cl in L/hr/kg, and Half-life in minutes. The percentages and corresponding ranges are also given for different parameters.*

Flumazenil usage should be monitored closely as it has been linked to seizures, particularly in patients on long-term benzodiazepines or in overdose cases involving serious cyclic antidepressant overdose. Practitioners are advised to adjust flumazenil dosage on a case-by-case basis and be ready to handle any resulting seizures.*

This is a description of Flumazenil injection, USP with a concentration of 0.1 mg/ml in a 5mL vial for intravenous use only. The medication should be stored between 15 to 30 degrees Celsius and out of children's reach. It is manufactured by Hikma Farmaceutica (Portugal), S.A. and distributed by Henry Schein, Inc. under the item number 2580470. Prescription use only.*